73 material Form 8-K filings that 66 companies we cover made with the SEC in January 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Badger Meter reported fourth quarter and full year 2023 results in a press release furnished under Item 2.02. Fourth quarter net sales rose 24% to $182.4 million and diluted EPS rose 40% to $0.84, while full year sales reached $703.6 million and diluted EPS reached $3.14, up 39%. Growth in utility water sales and higher margins drove the results, which the company says it expects to support sales and earnings growth in 2024.
Q4 2023 net sales were $182.4 million, up 24% from $147.3 million a year earlier.
Q4 2023 operating profit margin was 17.6%, up 230 basis points from 15.3%.
Full year 2023 diluted EPS was $3.14, up from $2.26, and full year net cash from operations was $110.1 million.
Management said it is confident in growing sales and earnings year-over-year in 2024; a conference call was held January 26, 2024 at 10:00 AM Central.
Colgate-Palmolive reported fourth-quarter 2023 net sales of $4,950 million, up 7.0% from a year earlier, and GAAP diluted EPS of $0.87 versus $0.01, which lapped 2022 impairment charges. For full year 2023, net sales rose 8.5% to $19,457 million and GAAP diluted EPS rose 30% to $2.77. The company guided 2024 net sales growth of 1% to 4% and double-digit GAAP EPS growth.
4Q 2023 net sales $4,950 million, up 7.0%; diluted EPS $0.87 versus $0.01 in 4Q 2022
Full-year 2023 net sales $19,457 million, up 8.5%; diluted EPS $2.77 versus $2.13
2024 guidance: net sales growth of 1% to 4% and double-digit GAAP EPS growth, including a low-single-digit negative foreign exchange impact
Gentex reported fourth-quarter and full-year 2023 results on January 26, 2024, with record net sales and higher net income and earnings per share than a year earlier. The company also issued 2024 guidance for revenue of $2.45 billion to $2.55 billion and expects 2025 revenue of $2.65 billion to $2.75 billion. For shareholders, the filing shows sales and profit growth, while the company is still working to raise gross margin to a 35% to 36% target by the end of 2024.
Q4 2023 net sales were $589.1 million, up 19% from $493.6 million; net income was $116.9 million and diluted EPS was $0.50, versus $0.37 a year earlier.
Full-year 2023 net sales were $2.30 billion, up 20%; net income was $428.4 million and diluted EPS was $1.84, versus $1.36 in 2022.
2024 guidance: revenue of $2.45 billion to $2.55 billion and gross margin of 34% to 35%.
Q4 2023 revenue included one-time cost recoveries of approximately $5 million; the company repurchased $144.7 million of shares in 2023.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.